A detailed history of Kestra Advisory Services, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 24,346 shares of CORT stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,346
Previous 30,834 21.04%
Holding current value
$1.07 Million
Previous $776,000 1.93%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $144,098 - $223,706
-6,488 Reduced 21.04%
24,346 $791,000
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $650,597 - $846,701
30,834 New
30,834 $776,000
Q1 2021

May 10, 2021

SELL
$23.49 - $30.56 $236,591 - $307,800
-10,072 Closed
0 $0
Q4 2020

Jan 20, 2021

BUY
$16.78 - $27.3 $169,008 - $274,965
10,072 New
10,072 $264 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $4.71B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.